Brief: Ventyx Biosciences Announces Completion Of Enrollment Of Phase 2 Trial Of VTX002 In Ulcerative Colitis

Ventyx Biosciences

07/06/2023 12:23

June 7 (Reuters) - Ventyx Biosciences Inc  VTYX.O :
    * VENTYX BIOSCIENCES ANNOUNCES COMPLETION OF ENROLLMENT OF
THE
PHASE 2 TRIAL OF VTX002 IN ULCERATIVE COLITIS AND THE PHASE 2
TRIAL OF VTX958 IN PLAQUE PSORIASIS
    * VENTYX BIOSCIENCES ANNOUNCES COMPLETION OF ENROLLMENT OF
THE
PHASE 2 TRIAL OF VTX002 IN ULCERATIVE COLITIS AND THE PHASE 2
TRIAL OF VTX958 IN PLAQUE PSORIASIS

Source text for Eikon:  ID:nGNX4R2ZY3 
Further company coverage:  VTYX.O